Health Care/Hospital Global News & Press Release Distribution

Health Care/Hospital

All
APAC

CE Certification for AI-based Medical Solutions of JLK Inspection: AI-based Brain Image Analysis (JBS-01K) and AI-based Prostate Image Analysis (JPC-01K) Solutions

SEOUL, South Korea, May 29, 2019 /PRNewswire/ -- JLK Inspection , a company specializing in world-class AI-based medical imaging solutions and a company of theBorn2Global Centre , has developed JPC-01K

2019-05-29 20:30 1481

CE Certification for AI-based Medical Solutions of JLK Inspection: AI-based Brain Image Analysis (JBS-01K) and AI-based Prostate Image Analysis (JPC-01K) Solutions

Sihuan Pharm Obtained Phase I to III Clinical Trial Approval for the Third Generation of EGFR Inhibitor XZP-5809

HONG KONG, May 29, 2019 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460), the largest cardio-cerebral vascular ("CCV") drug manufacturer inChina's prescription drug market, announced the third generation of EGFR inhibitor XZP-5809, a Category 1 innovative drug developed by t...

2019-05-29 18:00 4929

Samsung BioLogics to Showcase End-to-End CDMO Capabilities at BIO International 2019

INCHEON, South Korea, May 28, 2019 /PRNewswire/ -- For the ninth consecutive year since the company's foundation in 2011, Samsung BioLogics will be showcasing its full end-to-end CDMO capabilities at the BIO International 2019 convention inPhiladelphia, PA, June 3rd to 6th.

2019-05-29 12:27 1850

Samsung BioLogics to Showcase End-to-End CDMO Capabilities at BIO International 2019

Alphamab Oncology Announces Completion of US$60 Million Series B Financing

SUZHOU, China, May 28, 2019 /PRNewswire/ -- Alphamab Oncology, a leading biopharmaceutical company dedicated to global development of innovative biologics for cancer therapy, announced today that it has completed aUS$60 million Series B financing led by Hudson Bay Capital Management LP and parti...

2019-05-28 19:02 2628

World First Test Breakthrough to Boost IVF Success Rates

MELBOURNE, Australia, May 28, 2019 /PRNewswire/ -- A new revolutionary non-invasive embryo screening testwill reduce miscarriages and the time it takes to achieve a healthy live birth for the one-in-six Australian couples affected by infertility. In a world-first scientific breakthrough, Austral...

2019-05-28 13:40 1617

Nanjing YiGenCloud Institute aims to speed up the process of China's precision medicine with "intelligence"

NANJING, China, May 27, 2019 /PRNewswire/ -- Xinjun He, Ph.D., the executive director of Nanjing YiGenCloud Institute, a leading medical big data AI company inChina, described the blueprint of their China's precision medicine at the Nature conference: Genome Variation in Precision Medicine 2019he...

2019-05-27 20:25 2289

After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Investor

NESS ZIONA, Israel, May 27, 2019 /PRNewswire/ -- Ori Yehudai: "I took a company worth$3 million and sold it to IFF at $7.1 billion in 2018. In my opinion, the success of our cannabis company will be to build an industrial pharmaceutical company with the strictest standards, we had two such plants...

2019-05-27 20:05 2551

After $7.1 Billion Sale Of Frutarom, Ori Yehudai To Join The Sade Group As Active Chairman and Investor

Sihuan Pharm Becomes the First Chinese Company that was Granted Approval for "Non-PVC Solid-Liquid Double Chamber Bag for Ceftazidime/Sodium Chloride Injection"

HONG KONG, May 27, 2019 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: 0460) ("Sihuan Pharmaceutical" or the "Group"), the largest cardio-cerebral vascular ("CCV") drug manufacturer in China's prescription drug market, announced the "non-PVC solid-liquid double chamber bag for ...

2019-05-27 17:08 5062

111 to Collaborate with MSH to Build Internet Pharmaceutical and Healthcare Service Closed-loop System

SHANGHAI, May 24, 2019 /PRNewswire/ -- Following 111, Inc.'s (NASDAQ: YI) ("111" or the "Company") strategic partnership with Manulife-Sinochem last year, the Company has reached another milestone. OnMay 24, 111 and MSH, a world leader in the design and management of international healthcare solu...

2019-05-24 22:45 8413

CTONG-OrigiMed New Clinical Trial Sharing Platform Launched during the 3rd OrigiMed Summit for Cancer Discovery

SHANGHAI, May 24, 2019 /PRNewswire/ -- With fast advances in the medical industry, onMay 11, 2019, the third OrigiMed Summit for Cancer Discovery: Immunotherapy and Targeted Therapy was successfully held inGuangzhou. The summit was sponsored by the Chinese Thoracic Oncology Group (CTONG) and the ...

2019-05-24 19:00 4467

CTONG-OrigiMed New Clinical Trial Sharing Platform Launched during the 3rd OrigiMed Summit for Cancer Discovery

B dot Medical Developing Ultra-compact Proton Cancer Therapy System That Can Replace X-ray Cancer Therapy System

TOKYO, May 24, 2019 /PRNewswire/ -- B dot Medical Inc. announced on May 24 that the company has initiated the development of an ultra-compact proton cancer therapy system that can replace the commonly used x-ray cancer therapy system (LINAC). More than 180,000 patients have been treated in proto...

2019-05-24 14:00 2522

Ovid Therapeutics to Present at the 12th International Epilepsy Colloquium

First scientific presentation of OV-935 (TAK-935) safety and tolerability data in developmental and epileptic encephalopathies from the Phase1b/2a clinical trial Study met primary safety and tolerability endpoints and showed initial evidence of potential efficacy in seizure reduction Data encou...

2019-05-24 05:04 7435

APRINOIA Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinson's Research

TAIPEI, , May 23, 2019 /PRNewswire/ -- APRINOIA Therapeutics, a clinical-stage biotechnology company with a pipeline of therapeutics and imaging diagnostics for neurodegenerative diseases, announces today that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson'...

2019-05-23 20:00 2933

MGI introduces total solution for single cell RNA sequencing using MGISEQ-2000 sequencing platform compatible with 10x Genomics

TOKYO, May 23, 2019 /PRNewswire/ -- MGI , a subsidiary of global genomics leader BGI Group, announced it will begin marketing a total solution for single cell RNA Sequencing as part of the 10x Genomics' Compatible Product Partner Program on MGI's MGISEQ and BGISEQ sequenci...

2019-05-23 19:02 2906

Phebra establishes new subsidiary in Canada and announces marketing approval for its IV Arsenic Trioxide Solution

SYDNEY, May 23, 2019 /PRNewswire/ -- Australian pharmaceutical firm Phebra (the 'Company') has continued its international business expansion with the opening of its subsidiary inMontreal, Canada. The new entity, Phebra Canada, will be headed byTony Romagnino, Vice President of Phebra's current N...

2019-05-23 17:00 1781

Tencent Miying Launches AI-supported Auxiliary Diagnostic System

KUNMING, China, May 22, 2019 /PRNewswire/ -- Tencent today announces the launch of an AI-supported auxiliary diagnostic system for conducting digital colposcopy at the Global Digital Ecosystem Summit being held inKunming, China. This latest technology can rapidly identify the cervical transforma...

2019-05-23 04:47 7532

China SXT Pharmaceuticals, Inc. Being Admitted to Hi-tech Zone of Huangshan City in Anhui Province

TAIZHOU, China, May 22, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces ("TCMPs"), announced today the laun...

2019-05-22 23:20 6982

Vitaeris Announces Multiple Scientific Presentations Involving Clazakizumab at the 2019 American Transplant Congress

- Anti-Interleukin 6 Monoclonal Antibody for Antibody-Mediated Kidney Transplant Rejection - 8 Oral & Poster Presentations VANCOUVER, British Columbia, May 22, 2019 /PRNewswire/ -- Vitaeris Inc. (Vitaeris) today announced that eight abstracts involving or related to clazakizumab, Vitaeris' pro...

2019-05-22 20:30 1785

Scientists Identify New Therapeutic Target for Fatty Liver Disease

* Preclinical study highlights a novel therapy for the treatment of fatty liver disease, which affects up to 25% of the global population * Inhibiting interleukin 11 (IL11) signalling addresses multiple aspects of non-alcoholic steatohepatitis (NASH), including hepatic inflammation and fibros...

2019-05-22 18:24 1952

FDA Approves SORILUX(R) for Adolescent Plaque Psoriasis

ADELAIDE, Australia, May 22, 2019 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce that the US Food and Drug Administration (FDA) has approved SORILUX® (calcipotriene) Foam, 0.005% in adolescents. SORILUX is now approved for treating plaque psoriasis of the scalp and b...

2019-05-22 18:00 6561

1 ... 249 250 251252253 254